These outcomes, together with a previous report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two support the thought of targeting ACKR3 as a novel method to modulate the opioid technique, which could open new therapeutic avenues for opioid-associ